on dissolution of Solvay Biochemicals (Taixing) Limited amounting to 89 MB from other comprehensive income to the profit of the year 2018. Summary of Performance For the year 2019, the Company and its
for the first quarter ending 31 March 2018, which has already been examined by the Company’s auditor, the results can be summarized as follows; Performance Highlights for Q1/2018 Net Profit attributed
subsidiaries for Year 2017 period ended December 31, 2017 and would like to clarify on the annual operating results as follows: The consolidated net profit attributable to equity owners of the Company for the
36,226 Total Liabilities 4,749 Equity 31,478 Total Revenue 50,806 Net Profit 2,896 %net profit per Total Revenue 5.70% 4.2 Investment Proportion (Shareholding Proportion) Name Shares Before Shareholding
Project), with revenue from sales. - Real estate development business expected to occurred in that quarter. In addition, the company realizes profit from buying these two businesses since the purchase price
173,892 91.30 Income from Sevice 60,291 107,527 (47,236) (43.93) Cost of Sale of Goods (244,903) (151,506) 93,397 (61.65) Cost of Service (34,589) (59,328) (24,739) 41.70 Gross Profit 145,153 87,155 57,998
% ( Total consolidated sales and services income excluding construction revenue under concession agreement of 2,100.73 million Baht, decreased by 121.19 million Baht or 5.45%) and Net profit attributable to
and the increasing in competition among entrepreneurs under the situation of excess supply from products and raw materials coming in from various countries. Therefore those factors have been affecting
excess supply. These factors affect the sales volume and selling price. Therefore has a direct impact on the company's gross profit and net profit. Moreover, the Company and its subsidiaries have set aside
operators in the condition of excess supply have affected the selling price. The contracted volume and selling price therefore have a direct impact on the company's gross profit and net profit, although the